U.S. Market Projected to Hit USD 7.06 Billion by 2035 While Europe Market Expected to Reach USD 6.42 Billion as Aging Male Population Fuels Demand for Advanced BPH Therapies.Austin, United States, May ...

The coprimary efficacy endpoints were the proportion of patients with a 30% or greater improvement in IPSS from baseline to 3 months and the mean IPSS change from baseline to 12 months. The co-primary ...

UVA Health Prince William Medical Center has begun offering Aquablation therapy, an advanced AI-powered treatment for benign prostatic hyperplasia (BPH), or enlarged prostate, expanding access to ...

Study showed immediate improvement in symptoms after intentional retrieval of device at 6 ...

Data Supported the FDA Approval of the Zenflow Spring® Implant and Delivery System for BPHAdditional presented data highlights patient ...

DEAR DR. ROACH: I am 79. Two recent tests confirmed that my PSA level was 4.6 ng/mL. Previously, my results were never higher than 1.4 ng/mL. Flomax has been a necessity for me for the past 20 years, ...

A 77-year-old man suffering from a severely enlarged prostate was treated using an advanced minimally invasive laser ...

Today, the American Urological Association (AUA) released the 2026 Management of Lower Urinary Tract Symptoms (LUTS) ...

Benign prostatic hyperplasia (BPH) is a non-malignant enlargement of the prostate gland that commonly affects men over 50 and is a leading cause of lower urinary tract symptoms (LUTS). Symptoms ...

An enlarged prostate—also known as benign prostatic hyperplasia (BPH)—is a natural sign of aging that affects half of all men over the age of 40. The good news is this condition does not increase your ...

the hospital, the patient had been suffering from prolonged difficulty in urination along with repeated episodes of urinary retention, which had considerably impacted his quality of life ...